Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome

Clinical Endocrinology

Volumn 47, Issue 2, 1997, Pages 123-135

  Losa, Marco ^b   Von Werder, Klaus ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

^c Schlosspark Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PENTETREOTIDE; SOMATOMEDIN C; SOMATOSTATIN;

ACROMEGALY; CARCINOID; CELL HYPERPLASIA; CLINICAL FEATURE; DIAGNOSTIC IMAGING; ECTOPIC HORMONE PRODUCTION; ENDOCRINE TUMOR; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HYPERPROLACTINEMIA; HYPOPHYSECTOMY; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNOHISTOCHEMISTRY; PANCREAS TUMOR; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SOMATIC CELL;

EID: 0030832510     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2311048.x     Document Type: Review

References (93)

1. Aida, M., Furukawa, Y., Hanyu, K., Saito, Y., Matsumo, M., Matoba, N., Kimura, Y., Miura, K., Sato, T. & Tamahashi, N. (1977) Familial multiple endocrine neoplasia with a pancreatic carcinoid tumor. Journal of Clinical and Experimental Medicine, 101, 152-159 (in Japanese).
2. Asa, S.L., Scheithauer, B.W., Bilbao, J.M., Horvath, E., Ryan, N., Kovacs, K., Randall, R.V., Laws, E.R., Singer, W., Linfoot, J.A., Thorner, M.O. & Vale, W. (1984) A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. Journal of Clinical Endocrinology and Metabolism, 58, 796-803.
3. Asa, S.L., Kovacs, K., Stefaneanu, L., Horvath, E., Billestrup, N., Gonzales-Manchon, C. & Vale, W. (1992) Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology, 131, 2083-2089.
4. Ashcraft, M.W., Hartzband, P.I., Van Herle, A.J., Bersch, N. & Golde, D.W. (1983) A unique growth factor in patients with acromegaloidism Journal of Clinical Endocrinology and Metabolism, 57, 272-276.
5. Barkan, A.L., Shenker, Y., Grekin, R.J., Vale, W.W., Lloyd, R.V. & Beals, T.F. (1986) Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. Journal of Clinical Endocrinology and Metabolism, 63, 1057-1064.
6. Barkan, A.L., Shenker, Y., Grekin, R.J. & Vale, W.W. (1988) Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995. Cancer 61, 221-226.
7. Barth, R.J., Constant, R.B., Parker, M.W., Mueller, G.L., Kovacs, K. & Thorner, M.O. (1991) Preoperative diagnosis of acromegaly by growth hormone-releasing factor radioimmunoassay. Military Medicine, 156, 375-378.
8. Berelowitz, M., Szabo, M., Frohman, L.A., Firestone, S., Chu, L. & Hintz, R.L. (1981) Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212, 1279-1281.
9. Berger, G., Trouillas, J., Bloch, B., Sassolas, G., Berger, F., Partensky, C., Chayvialle, J.A., Brazeau, P., Claustrat, B., Lesbros, F. & Girod, C. (1984) Multihormonal carcinoid tumor of the pancreas secreting growth hormone-releasing factor as a cause of acromegaly. Cancer, 54, 2097-2108.
10. Bertherat, J., Turpin, G., Rauch, C., Li, J.Y., Epelbaum, J., Sassolas, G. & Schaison, G. (1994) Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and a-subunit-secreting tumors from acromegalic patients responsive to octreotide. Journal of Clinical Endocrinology and Metabolism, 79, 1457-1464.
11. Bilezikjian, L.M. & Vale, W.W. (1983) Stimulation of adenosine 3′, 5′-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro. Endocrinology, 113, 1726-1731.
12. Billestrup, N., Swanson, L.W. & Vale, W. (1986) Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proceedings of the National Academy of Sciences USA, 83, 6854-6857.
13. Blevins, L.S. Jr., Hall, G.S., Madoff, D.H., Laws, E.R. & Wand, G.S. (1992) Case report: acromegaly and Cushing's disease in a patient with synchronous pituitary adenomas. American Journal of the Medical Sciences, 304, 294-297.
14. Boizel, R., Halimi, S., Labat, F., Cohen, R. & Bachelot, I. (1987) Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment. Journal of Clinical Endocrinology and Metabolism, 64, 304-308.
15. Bowers, C.Y. (1943) GH releasing peptides-structure and kinetics. Journal of Pediatric Endocrinology, 6, 21-31.
16. Brar, A.K., Brinster, R.L., & Frohman, L.A. (1984) Immunohistochemical analysis of human growth hormone-releasing hormone gene expression in transgenic mice. Endocrinology, 125, 801-809.
17. Brazeau, P., Ling, N., Bohlen, P., Esch, F., Ying, S.Y. & Guillemin, R. (1982a) Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proceedings of the National Academy of Sciences USA, 79, 7909-7913.
18. 2 biochemical and Biophysical Research Communications, 109, 588-594.
19. Buse, J., Buse, M.G. & Roberts, W.J. Jr. (1961) Eosinophilic adenoma of the pituitary and carcinoid tumor of the rectosigmoid area. Journal of Clinical Endocrinology and Metabolism, 21, 735-738.
20. Carroll, D.G., Delahunt, J.W., Teague, C.A., Cooke, R.R., Adams, E.F., Christofides, N.D., Bloom, S.R., Terenghi, G. & Polak, J.M. (1987) Resolution of acromegaly after removal of a bronchial carcinoid shown to secrete growth hormone releasing factor. Australian and New Zealand Journal of Medicine, 17, 63-67.
21. Chadenas, D., Pinsard, D., Mellierer, D., Trouillas, J., Zafrani, E.S., Pradayrol, L., Sassolas, G., Li, Y., Girod, C. & Aumaitre, J. (1985) Tumeur pancreatique endocrine secretant de la somatostatine et de la somatocrinine. Presse Medicale, 14, 2129-2134.
22. Ch'ng, J.L.C., Christofides, N.D., Kraenzlin, M.E., Keshavarzian, A., Burrin, J.M., Woolf, I.L., Hodgson, H.J.F. & Bloom, S.R. (1985) Growth hormone secretion dynamics in a patient with ectopic growth hormone-releasing factor production. American Journal of Medicine, 79, 135-138.
23. Dabek, J.T. (1974) Bronchial carcinoid tumor with acromegaly in two patients. Journal of Clinical Endocrinology and Metabolism, 38, 329-333.
24. Dayal, Y., Ling, H.D., Tallberg, K., Reichlin, S., Delellis, R.A & Wolfe, H.J. (1986) Immunocytochemical demonstration of growth hormone-releasing factor in gastrointestinal and pancreatic endocrine tumors. American Journal of Clinical Pathology, 85, 13-20.
25. de Herder, W.W., Krenning, E.P., Malchoff, C.D., Hofland, L.J., Reubi, J.C., Kwekkeboom, D.J., Yoe Oei, H., Pols, H.A.P., Bruining, H.A., Nobels, F.R.E. & Lamberts, S.W.J. (1994) Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. American Journal of Medicine, 96, 305-312.
26. Deuben, R.R. & Meites, J. (1964) Stimulation of pituitary growth hormone release by a hypothalamic extract in vitro. Endocrinology, 74, 408-414.
27. Ezzat, S., Asa, S.L., Stefaneanu, L. et al. (1994) Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid. Journal of Clinical Endocrinology and Metabolism, 78, 555-560.
28. Faglia, G., Arosio, M. & Bazzoni, N. (1992) Ectopic acromegaly. Endocrinology and Metabolism Clinics of North America, 21, 575-595.
29. Frohman, L.A. (1984) Growth hormone-releasing factor: a neuroendocrine perspective. Journal of Laboratory and Clinical Medicine, 103, 819-832.
30. Frohman, L.A. & Downs, T.R. (1986) Measurement of growth hormone releasing factor. In Neuroendocrine Peptides (Methods in enzymology, no. 124), (ed. P.M. Conn), pp. 371-389. Academic Press, New York.
31. Frohman, L.A. & Jansson, O. (1986) Growth hormone-releasing hormone. Endocrine Reviews, 7, 223-253.
32. Frohman, L.A., Szabo, M., Berelowitz, M. & Stachura, M.A. (1980) Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. Journal of Clinical Investigation, 65, 43-54.
33. Frohman, L.A., Downs, T.R. & Brar, A.K. (1991) Transgenic growth hormone-releasing hormone (GHRH) production: a model for GHRH hypersecretion. In Molecular and Clinical Advances in Pituitary Disorders (ed. S. Melmed & R.J. Robbins), pp. 239-246. Blackwell Scientific Publications, Boston.
34. Genka, S., Soeda, H., Takahashi, M., Katakami, H., Sanno, N., Osamura, Y., Fuchinoue, T. & Teramoto, A. (1995) Acromegaly, diabetes insipidus, and visual loss caused by metastatic growth hormone-releasing hormone-producing malignant pancreatic endocrine tumor in the pituitary gland. Journal of Neurosurgery, 83, 719-723.
35. Gilsanz Peral, A., Gomez Balaguer, M., Alberola Carbonell, C., Pastor Guillem, J. & Costa Talens, P. (1987) Evidencia de la produccion por un tumor carcinoide pulmonar del factor liberador de la hormona de crecimiento causante de acromegalia. Medicina Clinica (Barc), 89, 789-792.
36. Glikson, M., Gil-Ad, I., Galun, E., Dresner, R., Zilberman, S., Halperin, Y., Okon, E., Laron, Z. & Rubinow, A. (1991) Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli. Acta Endocrinologica (Copenh), 125, 366-371.
37. Guillemin, R., Brazeau, P., Böhlen, P., Esch, F., Ling, N. & Wehrenberg, W.B. (1982) Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science, 218, 585-587.
38. Harris, P.E., Bouloux, P.M.G., Wass, J.A.H. & Besser, G.M. (1990) Successful treatment by chemotherapy for acromegaly associated with ectopic growth hormone releasing hormone secretion from a carcinoid tumour. Clinical Endocrinology, 32, 315-321.
39. Hawkins, F., Sanchez Moro, V., Aguirre, M. et al. (1985) Acromegaly and bronchial carcinoid. Effect of the removal of the latter. Chest, 88, 149-152.
40. 111In-octreolide scintigraphy in oncology. Metabolism, 41, Suppl. 2, 83-86.
41. Lamberts S.W.J., Krenning, E.P. & Reubi, J.C. (1991) The role of somatostatin and its analogs in the treatment of tumors. Endocrine Review, 12, 450-482.
42. Lefebvre, S., De Paepe, L., Abs, R., Rahler, J., Selvais P. & Maiter, D. (1995) Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion. European Journal of Endocrinology, 133, 320-324.
43. Leveston, S.A., Mc Keel, D.W., Buckley, P.J. et al. (1981) Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor. Journal of Clinical Endocrinology and Metabolism, 53, 682-689.
44. Ling, N., Baird, A., Wehrenberg, W.B., Ueno, N., Munegumi, T. & Brazeau, P. (1984a) Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. Biochemical and Biophysical Research Communications, 123, 854-860.
45. Ling, N., Baird, A., Wehrenberg, W.B. et al. (1984b) Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1. Biochemical and Biophysical Research Communications, 122, 304-310.
46. Ling, N., Esch, F., Bohlen, P., Brazeau, P., Wehrenberg, W.B. & Guilleman, R. (1984c) Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proceedings of the National Academy of Sciences USA, 81, 4302-4306.
47. 2+ mobilisation with stimulation of growth hormone (GH) release by GH-releasing factor in dispersed normal male rat pituitary cells. Endocrinology, 118, 239-243.
48. Losa, M. (1995) Octreotide treatment of pituitary adenomas. Cancer Journal, 8, 65-71.
49. Losa, M., Bock, L., Schopohl, J., Stalla, G.K., Müller, O.A. & von Werder, K. (1984) Growth hormone releasing factor infusion does not sustain elevated GH-levels in normal subjects. Acta Endocrinologica (Copenh), 107, 462-470.
50. Losa, M., Wolfram, G., Mojto, J., Schopohl, J., Spiess, Y., Hüber, R., Müller, O.A. & von Werder, K. (1990) Presence of growth hormone-releasing hormone-like immunoreactivity in human tumors: characterization of immunological and biological properties. Journal of Clinical Endocrinology and Metabolism, 70, 62-68.
51. Losa, M., Schopohl, J. & von Werder, K. (1993) Ectopic secretion of growth hormone-releasing hormone in man. Journal of Endocrinological Investigation, 16, 69-81.
52. Melmed, S. (1990) Acromegaly. New England Journal of Medicine, 322, 966-977.
53. Melmed, S., Ezrin, C., Kovacs, K., Goodman, R.S. & Frohman, L.A. (1985) Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. New England Journal of Medicine, 312, 9-17.
54. Melmed, S., Ziel, F.H., Braunstein, G.D., Downs, T. & Frohman, L.A. (1988) Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor. Journal of Clinical Endocrinology and Metabolism, 67, 395-399.
55. Moller, D.E., Moses, A.C., Jones, K., Thorner, M.O. & Vance, M.L. (1989) Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion. Journal of Clinical Endocrinology and Metabolism, 68, 499-504.
56. Mountcastle, R.B., Roof, B.S., Mayfield, R.K., Mordes, D.B., Sagel, J., Biggs, P.J. & Rawe, S.E. (1989) Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma. American Journal of the Medical Sciences, 298, 109-118.
57. Oberg, K., Skogseid, B. & Eriksson, B. (1989) Multiple endocrine neoplasia type 1 (MEN-1). Acta Oncologica, 28, 383-387.
58. Penny, E.S., Penman, E., Price, J., Rees, L.H., Sopwith, A.W., Wass, J.A.H. & Besser, G.M. (1984) Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. British Medical Journal, 289, 453-455.
59. Popovic, V., Micic, D., Damjanovic, S., Petakov, M., Manojlovic, D. & Micic, J. (1990) Discordance between growth hormone responses after growth hormone-releasing hormone (GHRH) and insulin hypoglycemia in ectopic GHRH syndrome. Endocrinologia Experimentalis, 24, 167-173.
60. Ramsay, J.A., Kovacs, K., Asa, S.L., Pike, M.J. & Thorner, M.O. (1987) Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in an acromegalic patient with multiple endocrine neoplasia type 1 syndrome. Cancer, 62, 445-450.
61. Reichlin, S. (1960) Growth and the hypothalamus. Endocrinology, 67, 760-773.
62. Rivier, J., Spiess, J. & Thorner, M. (1982) Characterization of a growth hormone-releasing factor from a human pancreatic islet tumor. Nature, 300, 276-278.
63. Roelfsema, F., Frölich, M., de Boer, H. & Harris, A.G. (1991) Octreotide treatment in acromegaly: a comparison between pen-treated and pump-treated patients in a cross-over study. Acta Endocrinologica (Copenh), 125, 43-48.
64. Roth, K.A., Wilson, D.M., Eberwine, J., Dorin, R.I., Kovacs, K., Bensch, K.G. & Hoffman, A.R. (1986) Acromegaly and pheochromocytoma: a multiple endocrine syndrome caused by a plurihormonal adrenal medullary tumor. Journal of Clinical Endocrinology and Metabolism, 63, 1421-1426.
65. Saeger, W., Puchner, M.J.A. & Lüdecke, D.K. (1994) Combined sellar gangliocytomas and pituitary adenoma in acromegaly or Cushing's disease. Virchows Archiv A, Pathological Anatomy and Histopathology, 425, 93-99.
66. Sano, T., Yamasaki, R., Saito, H. et al. (1987) Growth hormone-releasing hormone (GHRH)-secreting pancreatic tumor in a patient with multiple endocrine neoplasia type 1. American Journal of Surgical Pathology, 11, 810-819.
67. Sano, T., Asa, S.L. & Kovacs, K. (1988) Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocrine Reviews, 9, 357-373.
68. Sassolas, G., Chayvialle, J.A., Partensky, C. et al. (1983) Acromegalie: Expression clinique de la production de facteurs de liberation de l'hormone de croissance (GRF) par une tumeur pancreatique. Annales d'Endocrinologie (Paris), 44, 347-354.
69. Sassolas, G., Chatelain, P., Cohen, R. et al. (1984) Effects of human panereatic tumor growth hormone-releasing hormone (hpGRH 1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men. Journal of Clinical Endocrinology and Metabolism, 59, 705-710.
70. Scheithauer, B.W., Carpenter, P.C., Bloch, B. & Brazeau, P. (1984) Ectopic secretion of a growth hormone-releasing factor. American Journal of Medicine, 76, 605-616.
71. Schulte, H.M., Benker, G., Windeck, R., Olbrich, T. & Reinwein, D. (1985) Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: Dinamycs of multiple endocrine testing. Journal of Clinical Endocrinology and Metabolism, 61, 585-587.
72. Shalet, S.M., Beardwell, C.G., Mac Farlane, I.A., Ellison, M.L., Norman, C.M., Rees, L.H. & Hughes, M. (1979) Acromegaly due to production of a growth hormone releasing factor by a bronchial carcinoid tumor. Clinical Endocrinology, 10, 61-67.
73. Shintani, Y., Yoshimoto, K., Horie, H., Sano, T., Kanesaki, Y., Hosoi, E., Yokogoshi, Y., Bando, H., Iwahana, H., Kannuki, S., Matsumoto, K., Itakura, M. & Saito, S. (1995) Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features. Endocrine Journal, 42, 331-340.
74. Sönsken, P.H., Ayres, A.B., Braimbridge, M., Corrin, B., Davies, D.R., Jeremiah, G.M., Oaten, S.W., Lowy, C. & West, T.E.T. (1976) Acromegaly caused by pulmonary carcinoid tumours. Clinical Endocrinology, 5, 503-513.
75. Southgate, H.J., Archibold, G.P.R., El-Sayed, M.E., Wright, J. & Marks, V. (1988) Ectopic release of GHRH and ACTH from an adenoid cystic carcinoma resulting in acromegaly and complicated by pituitary infarction. Postgraduate Medical Journal, 64, 145-148.
76. Spero, M. & White, E.A. (1985) Resolution of acromegaly, amenorrhea-galactorrhea syndrome, and hypergastrinemia after resection of jejunal carcinoid. Journal of Clinical Endocrinology and Metabolism, 60, 392-395.
77. Spiess, J., Rivier, J. & Vale, W. (1983) Characterization of rat hypothalamic growth hormone-releasing factor. Nature, 303, 532-535.
78. Stefaneanu, L., Kovacs, K., Horvath, E., Asa, S.L., Losinski, N.E., Billestrup, N., Price, J. & Vale, W. (1989) Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. Endocrinology, 125, 2710-2718.
79. Thorner, M.O., Perryman, R.L., Cronin, M.J., Rogol, A.D., Draznin, M., Johanson, A., Vale, W., Horvath, E. & Kovacs, K. (1982) Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. Journal of Clinical Investigation, 70, 965-977.
80. Thorner, M.O., Frohman, L.A., Leong, D.A., Thominet, J., Downs, T., Hellmann, P., Chitwood, J., Vaughan, J.M., Vale, W., Besser, G.M., Lytras, M., Edwards, C.R.W., Schaaf, M., Gelato, M., Krieger, D.T., Marcovitz, S., Ituarte, E., Boyd, A.E., Malarkey, W.B., Blackard, W.G., Prioleau, G., Melmed, S. & Charest, N.J. (1984) Extrahypothalamic growth-hormone releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. Journal of Clinical Endocrinology and Metabolism, 59, 846-849.
81. uz Zafar M.S., Mellinger, R.C., Fine, G., Szabo, M. & Frohman, L.A. (1979) Acromegaly associated with a bronchial carcinoid tumor: evidence for ectopic production of growth hormone-releasing activity. Journal of Clinical Endocrinology and Metabolism, 48, 66-71.
82. Vance, M.L., Kaiser, D.L., Evans, W.S., Furlanetto, R., Vale, W., Rivier, J. & Thorner, M.O. (1985) Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of growth hormone releasing factor (1-40). Journal of Clinical Investigation, 75, 1584-1590.
83. von Gottschalk, J., Jänisch, W., Gerl, H., Knappe, G. & Rohde, W. (1986) Neue Aspekte in der Pathogenese der Akromegalie-Somatoliberinome Zentralblatt allgemaine Pathologie und pathologische Anatomie, 131, 229-242.
84. von Werder, K. (1993) Somatostatin analogues in pituitary adenomas. Recent Results in Cancer Research, 129, 25-44.
85. von Werder, K., Losa, M., Müller, O.A., Schweiberer, L., Fahlbusch, R. & Del Pozo, E. (1984) Treatment of metastasising GRF-producing tumour with a long-acting somatostatin analogue. Lancet, 2, 282-283 (letter).
86. von Werder, K., Losa, M., Stalla, G.K., Müller, O.A., Mayr, B., Schweiberer, L. & Fahlbusch, R. (1986) Long-term treatment of a metastasizing GRFoma with a somatostatin analogue (SMS 201-995) in a girl with gigantism. Scandinavian Journal of Gastroenterology, 21 (Suppl; 119), 238-242.
87. von Werder, K., Fahlbusch, R., Losa, M., Oeckler, R., Pichl, J. & Schopohl, J. (1987) Decision analysis of treatment options in acromegaly. In Acromegaly (ed. R.J. Robbins & S. Melmed), pp. 267-380. Plenum Publishing Co., New York.
88. von Werder, K., Losa, M., Stalla, G.K., Schopohl, J. & Müller, O.A. (1991) Measurement of human growth hormone- and corticotropin-releasing hormone. In Pituitary Adenomas: New Trends in Basic and Clinical Research (ed. G. Faglia, P. Beck-Peccoz, B. Ambrosi, P. Travaglini & A. Spada), pp. 215-225. Exerpta Medica, Amsterdam. International Congress Series 961.
89. Wilson, D.M. & Hoffman, A.R. (1986) Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor. Acta Endocrinologica, 113, 23-28.
90. Wilson, D.M., Ceda, G.P., Bostwick, D.G., Webber, R.J., Minkoff, J.R., Pont, A., Hintz, R.L., Bensch, K.G., Kraemer, F.B., Rosenfeld, R.G. & Hoffman, A.R. (1984) Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone releasing factor. Journal of Clinical Endocrinology and Metabolism, 59, 1002-1005.
91. Yamasaki, R., Saito, H., Kameyama, K., Hosoi, E. & Saito, S. (1988a) Secretion of growth hormone-releasing hormone in patients with idiopathic pituitary dwarfism and acromegaly. Acta Endocrinologica (Copenh), 117, 273-281.
92. Yamasaki, R., Saito, H., Sano, T., Kameyama, K., Yoshimoto, K., Hosoi, E., Matsumura, M., Harada, K. & Saito, S. (1988b) Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I. Endocrinologia Japonica, 35, 97-109.
93. Zimmerman, D., Young, W.F. Jr., Ebersold, M.J., Scheithauer, B.W., Kovacs, K., Horvath, E., Whitaker, M.D., Eberhardt, N.L., Downs, T.R. & Frohman, L.A. (1993) Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. Journal of Clinical Endocrinology and Metabolism, 76, 216-222.